Tag: i-FACTOR peptide enhanced bone graft

Cerapedics announces long-term data from pivotal study of i-FACTOR bone graft

Cerapedics has announced long-term follow-up data from its pivotal investigational device exemption (IDE) study of the i-FACTOR peptide-enhanced bone graft. Published data demonstrate fusion...
cerapedics

Cerapedics announces expansion of Colorado headquarters

Cerapedics has announced the expansion of the company's headquarters located in the Denver metropolitan area. Over the past 18 months, Cerapedics has grown from...

ISASS bone grafting policy statement features i-FACTOR peptide enhanced bone graft

The International Society for the Advancement of Spine Surgery (ISASS) recently issued a new bone grafting policy that features i‑FACTOR peptide enhanced bone graft...
financing

Use of i-FACTOR peptide enhanced bone graft more than doubles fusion...

The use of i-FACTOR peptide enhanced bone graft (Cerapedics) resulted in a 50% fusion rate, compared to a 20% fusion rate using allograft in...